Patients
Learn how PKG is changing lives for people with Parkinson’s disease.
Visit SiteHealthcare Professionals
Learn about PKG continuous, objective measures for Parkinson’s disease healthcare professionals.
Visit SiteClinical Trials
Developed by Global Kinetics Pty Ltd, the PKG® is an innovative digital health technology.
Visit Site
Welcome to PKG!
Choose a link to continue.
The PKG® System
Influencing clinical management and outcomes for people with Parkinson’s disease.
The PKG® system provides continuous, objective, ambulatory assessment of movement disorder symptoms, such as tremor, dyskinesia and bradykinesia during activities of daily living and in the patient's home environment.
ABOUT GLOBAL KINETICS
Global Kinetics
Global Kinetics is committed to improving the lives of patients with neurologic conditions using advanced digital health technologies. The company was formed in 2007 to commercialize its lead product, the Personal KinetiGraph (PKG). The PKG System including its proprietary, clinically proven algorithms, enables the precise monitoring, quantification, and reporting of movement disorder symptoms. To date, Global Kinetics has supported clinical research and treatment decisions by healthcare professionals who have treated more than 35,000 patients, generating more than 9,000,000 hours of clinical data from the FDA-cleared, CE-marked, TGA-approved PKG System. Global Kinetics is a privately held company, headquartered in Melbourne, Australia with offices in the United Kingdom and the United States.